Savara
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Savara and other ETFs, options, and stocks.About SVRA
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis.
CEOMatthew Pauls
CEOMatthew Pauls
Employees59
Employees59
HeadquartersLanghorne, Pennsylvania
HeadquartersLanghorne, Pennsylvania
Founded1995
Founded1995
Employees59
Employees59
SVRA Key Statistics
Market cap337.03M
Market cap337.03M
Price-Earnings ratio-3.92
Price-Earnings ratio-3.92
Dividend yield—
Dividend yield—
Average volume3.26M
Average volume3.26M
High today$2.81
High today$2.81
Low today$1.60
Low today$1.60
Open price$1.92
Open price$1.92
Volume25.01M
Volume25.01M
52 Week high$5.11
52 Week high$5.11
52 Week low$1.60
52 Week low$1.60
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own SVRA. This list is generated using Robinhood data, and it’s not a recommendation.